Bartholomew Tyler S, Tookes Hansel E, Bullock Corinne, Onugha Jason, Forrest David W, Feaster Daniel J
Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA.
Division of Infectious Diseases, Miller School of Medicine, University of Miami, Miami, FL, USA.
Int J Drug Policy. 2020 Apr;78:102716. doi: 10.1016/j.drugpo.2020.102716. Epub 2020 Mar 5.
Injection drug use (IDU) remains a significant public health problem. IDU has been associated closely with the opioid crisis; driving overdose, HIV, and Hepatitis C (HCV) infection nationwide. Syringe services programs (SSPs) remain pivotal evidence-based interventions to reduce harm and engage subgroups of people who inject drugs (PWID). This study aims to provide policy considerations from the IDEA SSP, the first legal SSP in the state of Florida.
We performed a latent class analysis on patterns of substance use among participants (N = 982) newly enrolled in a syringe services program (SSP). Associations between classes of substance use and sociodemographic variables, risky injection and sex behaviors, HIV/HCV status and syringe coverage were analyzed using the R3STEP and BCH 3-step procedures in latent class regression.
We found a three-class solution: Heroin-Dominant class (73.9%), Methamphetamine-Dominant class (9.5%) and Heroin/Cocaine class (16.6%). Compared to Heroin-Dominant class, the Heroin/Cocaine class were more likely to report homelessness, sharing works, unprotected sex, public injection, and to be HCV positive. Compared to both Heroin-Dominant and Heroin/Cocaine classes, the Methamphetamine-Dominant class were more likely to be male, Hispanic, gay or bisexual orientation, HIV positive, to report unprotected sex and sex with PWID. In addition, the lowest and highest syringe coverage were among those in the Heroin/Cocaine and Methamphetamine-Dominant classes, respectively.
Existing interventions among this population to mitigate infectious disease risk, such as SSPs, can be a used to engage differing PWID populations. However, multi-component, targeted preventive interventions and need-based syringe distribution policies are required to further reduce HIV and HCV risk among various PWID populations.
注射吸毒仍是一个重大的公共卫生问题。注射吸毒与阿片类药物危机密切相关,在全国范围内导致过量用药、艾滋病毒和丙型肝炎(HCV)感染。注射器服务项目(SSP)仍然是减少伤害和接触注射吸毒者(PWID)亚群体的关键循证干预措施。本研究旨在提供来自佛罗里达州首个合法注射器服务项目IDEA SSP的政策考量。
我们对新加入注射器服务项目(SSP)的参与者(N = 982)的物质使用模式进行了潜在类别分析。使用潜在类别回归中的R3STEP和BCH 3步程序分析了物质使用类别与社会人口统计学变量、危险注射和性行为、艾滋病毒/丙型肝炎状态及注射器覆盖率之间的关联。
我们发现了一个三类解决方案:以海洛因为主的类别(73.9%)、以甲基苯丙胺为主的类别(9.5%)和海洛因/可卡因类别(16.6%)。与以海洛因为主的类别相比,海洛因/可卡因类别更有可能报告无家可归、共用工具、无保护性行为、公共注射以及丙型肝炎呈阳性。与以海洛因为主和海洛因/可卡因类别相比,以甲基苯丙胺为主的类别更有可能是男性、西班牙裔、同性恋或双性恋取向、艾滋病毒呈阳性、报告无保护性行为以及与注射吸毒者发生性行为。此外,注射器覆盖率最低和最高的分别是以海洛因/可卡因类别和以甲基苯丙胺为主的类别中的人群。
针对这一人群减轻传染病风险的现有干预措施,如注射器服务项目,可以用来接触不同的注射吸毒者群体。然而,需要多成分、有针对性的预防干预措施和基于需求的注射器分发政策,以进一步降低不同注射吸毒者群体中的艾滋病毒和丙型肝炎风险。